Johnson & Johnson

Johnson & Johnson is an American  multinational pharmaceutical medical devices and consumer packaged goods manufacturer whose headquarters are located in New Brunswick, New Jersey. The corporation includes some 250 subsidiary companies with operations in over 60 countries employing approximately 118,000 people and our products sold in over 175 countries.

 

Our Family of Companies comprises:

The world’s sixth-largest consumer health company

The world’s largest and most diverse medical devices and diagnostics company

The world’s fifth-largest biologics company

And the world’s eighth-largest pharmaceuticals company

 

Our Public Policy Advisory Committee is composed of independent Directors and one of the Company’s Vice Chairmen, Executive Committee, and the Vice Presidents for Corporate Affairs, Government Affairs and Policy and Johnson & Johnson Supply Chain. The Public Policy Advisory Committee:

  • Reviews the Company’s policies, programs and practices on public health issues regarding the environment and the health and safety of employees.
  • Reviews the Company’s governmental affairs and policies and other public policy issues facing the Company.
  • Advises and makes recommendations to the Board on these issues as appropriate.

 

At Johnson & Johnson, we believe that it is important to encourage the development of sound public policy, worldwide. With good policy, we can better serve doctors, nurses and patients, our employees and our communities around the globe. Johnson & Johnson advocates for a variety of important policy positions before governments. Around the world we consistently lobby for enhancement to healthcare systems. We also monitor and engage on business policies, as well as a range of emerging scientific issues such as green chemistry and product stewardship. We have supported climate change legislation to reduce greenhouse gases.

 

In the U.S. we have advocated for the passage of the State Children’s Health Insurance (SCHIP), enhancing access for the uninsured, preserving and creating jobs, enhancing infrastructure under the stimulus bill, disclosing funding to physicians, patent reform, liability reform, health care reform, support for incentives for programmes in wellness and prevention, support for a pathway to licence biosimilar medicines, support for enhanced comparative effectiveness research, corporate tax reform initiatives and many other issues. We support  a strong and healthy Food and Drug Administration and disclosure of payments that companies make to physicians. We also support a tax credit for renewable energy.

 

Johnson & Johnson works in collaboration with many coalitions and partnerships to advance good public policy. Some of the groups we partner with are:

  • Healthcare Leadership Council
  • Rand Compare Project
  • CEO Cancer Gold Standard
  • Partnership to fight Chronic Disease
  • 21st Century Coalition for Patent Reform
  • World Resources Institute
  • World Wildlife Fund
  • Carbon Disclosure Project
  • U.S. Climate Action Partnership (USCAP).

 

In the European Union, Johnson & Johnson works with:

  • European Justice Forum
  • European Policy Centre
  • Centre for Health, Ethics in Society (CHES)
  • European Health Leadership Programme at the INSEAD Business School
  • CSR Europe

 

Responsibility for activities we consider in determining our social performance is spread among several corporate and global functions. These include Global Procurement, Quality & Compliance Worldwide, Global Talent Management, Benefits and Health Resources, Worldwide Compensation, Health Care Compliance & Privacy and Public Affairs & Corporate Communications, Corporate Contributions, Government Affairs & Policy, Global Diversity & Inclusion, Worldwide Supply Chain, Worldwide Security and Legal. These functions report to the Corporate Group Operating Committee (GOC) and the Executive Committee, which report to the Board of Directors.

 

Johnson& Johnson Positions

 

Healthcare

As a member of the global health care community, we have a responsibility to advance quality health care through our actions as well as to work with others to help shape effective health care systems around the world that will serve the needs of people. No two countries have the same health care systems, and local and cultural values often play a role in how different health systems balance the demands of providing care with those of cost, access, choice, quality and medical advance. Using the vantage point of our broad base in healthcare we:

  • Work to address unmet medical needs through advance science and innovation, using our talents and commitment to improve healthcare;
  • Support efforts to enhance access to health care and healthcare products
  • Provide appropriate clinical and economic information about our products and treatments, as well as broad health, disease and prevention information, to individuals, health care practitioners, caregivers and payers in ways that facilitate health care decision-making;
  • Protect the privacy of personal medical information;
  • Lead by example in providing preventive, health-related and lifestyle modification tools and solutions to our employees and their families worldwide;
  • Work with others to improve the quality, cost effectiveness and accessibility to health care for people in developed and developing countries;
  • Promote strong regulatory bodies;
  • Enhance business models to ensure appropriate incentives and long-term sustainability.

 

 

 

Medical Innovation

Research advances have led to more accurate diagnoses, less invasive treatments, shorter hospital stays, fewer side effects and longer lives. But research and development is not enough to guarantee new and better therapies in the future. To ensure that research continues, investments are needed by both private and public entities. It is critical that companies conducting medical research operate in an environment that encourages and rewards investments in progress that addresses unmet medical needs. Investing in Medical Progress New or improved treatments can help to improve and save lives. Continuing investments in research and development are essential if we want tomorrow’s care to be even better.

 

Access to Medicines

We have a responsibility to help create a world where people across all economic and social circumstances can access the treatments they need. To enhance access to our health care products, we have many programs for those who cannot afford our medicines.

 

In the U.S., we are working to help people with little or no health insurance get access to the medicines they need. Our companies operate programs that provide discounts on medicines and other support to patients. The Johnson & Johnson Patient Assistance Foundation, Inc., provides free medicines, donated by the Johnson & Johnson operating companies, to patients that meet certain eligibility criteria.

We have a global access program for our HIV/AIDS medicines and have active research programs for diseases that affect the developing world, such as tuberculosis. Each year we also provide medicines and other products to people around the world through our product giving and disaster relief programs.

 

We strive to reduce our costs in order to maintain reasonable prices and broaden access to our health products. We also work with governments and international donors around the world to provide our products at affordable prices.

 

Wellness, Prevention & Health Education

The promotion of healthy lifestyles and the prevention of disease through lifestyle changes holds great promise for improving the health of people today and in the future. Johnson & Johnson supports many efforts to promote health and wellness and reduce preventable diseases.

 

Comprehensive health care includes preventing disease as well as treating sickness and managing chronic conditions through life. Programs that encourage prevention and disease management and those that provide effective incentives are vital to promoting good health.

 

We work to help educate people about health care issues and how to use the resources and services available to them.

 

Johnson & Johnson began offering health & wellness programs more than 20 years ago in the U.S. and is now expanding these efforts worldwide.
 

Ethical Research & Development

We adhere to the highest ethical standards in the work that is conducted in our laboratories and in our clinical research with people, across our Family of Companies. We review our research policies to ensure they’re aligned with ethical standards around the world.

 

Johnson & Johnson companies sponsor and support clinical trials in more than 40 countries, allowing for wide diversity among populations participating in research. We adhere to the principles of good clinical practices. Our Ethical Code of Conduct for R&D is intended to complement Our Credo by providing more specific standards of conduct and behaviour for physicians, clinical research scientists and others who are responsible for medical aspects of research and development.

 

Our efforts also encompass finding diagnostics, treatments and ways to deliver them where they are needed most. We have a strong commitment to the research and development of new treatments for infectious diseases that affect the developing world.

 

We seek to operate our businesses in alignment with societal norms and in accordance with accepted international standards for scientific work. We have research policies that address the specific issues of animal welfare, stem cell research and genetic research.

 

Product Quality & Safety

The quality and safety of our companies’ products is our top priority. Quality and safety policies drive every step of product design, manufacturing and marketing across our businesses. Our commitment to safety continues after products reach the marketplace.

 

Our quality systems aim to ensure our products perform the way they are supposed to and meet all regulatory requirements.

 

Product quality and safety start with the design of our products to ensure they match requirements. Materials and ingredients are checked against requirements to ensure purity, safety and efficacy. Finished products also undergo thorough safety assessments.

 

Beyond our companies’ own manufacturing, we also rely on other firms to produce finished goods and ingredients. The Johnson & Johnson Standards for Responsible External Manufacturing help us select partners who operate in a manner consistent with our values, and they help our manufacturing partners understand our expectations.

 

Our companies ensure that products are used appropriately by monitoring safety information and identifying potential safety issues. We also work to educate health care professionals on the appropriate use of prescription medicines and medical devices, and help people understand how to use health care products wisely.

 

We are committed to environmentally responsible operations and work with regulatory authorities around the world to ensure that the environment is protected.

Accountable Business Practices

To help ensure that we conduct business according to the values embodied in Our Credo, we have policies that define what we expect of the people within the Johnson & Johnson Family of Companies throughout the world. We provide our employees with comprehensive systems that support ethical behaviour and compliance with laws and regulations.

 

Our policies give clear direction on how to act according to our business values, as well as the laws and regulations where our companies operate around the world. Employees are required to follow the laws and regulations of the countries where they do business.

Our policies for responsible selling, marketing and interacting with health professionals require that our employees act according to the laws of the countries where we do business and comply with applicable industry codes of behaviour.

 

Transparency in Our Business Activities

Our primary goal is to make life-changing, long-term differences in human health and disease management through the products and services we provide. The patients and professionals who rely on our products place their trust in the reliability of our clinical research, the rigor of our scientific publications, the independence of professional education we fund and the integrity of our relationships with health care professionals.

Our companies work to prevent real or perceived conflicts of interest that may arise from relationships between companies and health care professionals. Consistent with our ongoing commitment to ensure ethical and transparent interactions with medical professionals, we regularly review and update our practices that guide interactions with health care professionals, institutions and other stakeholders in the health care system.

 

We believe in greater transparency regarding the relationships between health care companies and physicians. We are committed to begin voluntarily disclosing payments made to physicians by its U.S. pharmaceutical and medical device and diagnostics companies.

Johnson & Johnson was one of the first large health care companies to support the Physician Payments Sunshine Act, which was incorporated into the federal Patient Protection and Affordable Care Act of 2009.  On June 30, 2010, our U.S. commercial pharmaceuticals companies began voluntarily disclosing payments made to physicians during the first quarter of 2010.  Under the Patient Protection and Affordable Care Act, this type of disclosure is not required until 2013.

Janssen Pharmaceuticals, Inc.

Janssen Biotech, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Patriot Pharmaceuticals, LLC

Animas Corporation

ASP

Biosense Webster

Codman

Cordis

Depuy Mitek, Inc

Depuy Spine, Inc

Ethicon, Inc.

Ethicon Endo-Surgery

Johnson & Johnson Health Care Systems Inc.

LifeScan

Ortho Clinical Diagnostics

Therakos

Veridex, LLC

The Vision Care Institute, LLC

Vistakon

We post results of controlled clinical studies, regardless of their outcomes, online at ClinicalTrials.gov. Our researchers are committed to publishing results that are scientifically or medically important, including results that affect the registration or utilization of a Company product, as well as results from discontinued clinical research.

We recognize our responsibility to support health care professionals in their pursuit of current education so they may provide the best patient care possible. Our Pharmaceutical and Medical Device & Diagnostics companies in the U.S. disclose the nature and volume of grants they make for professional education.

Janssen Pharmaceuticals, Inc.

Janssen Biotech, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Patriot Pharmaceuticals, LLC

Animas Corporation

ASP

Biosense Webster

Codman

Cordis

Depuy Mitek, Inc

DePuy Orthopaedics, Inc.

Depuy Spine, Inc

Ethicon, Inc.

Ethicon Endo-Surgery

Johnson & Johnson Health Care Systems Inc.

LifeScan

Mentor Worldwide, LLC

Ortho Clinical Diagnostics

Therakos

Veridex, LLC

The Vision Care Institute, LLC

Vistakon

Our giving focuses on making life changing, lasting differences in the health of people who do not have access to medicine or quality medical care. Our Pharmaceutical and Medical Device & Diagnostics companies in the U.S. provide information on the contributions they make to charitable organizations in the health care field.

Janssen Pharmaceuticals, Inc.

Janssen Biotech, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Patriot Pharmaceuticals, LLC

Animas Corporation

ASP

Biosense Webster

Codman

Cordis

Depuy Mitek, Inc

DePuy Orthopaedics, Inc.

Depuy Spine, Inc

Ethicon, Inc.

Ethicon Endo-Surgery

Johnson & Johnson Health Care Systems Inc.

LifeScan

Mentor Worldwide, LLC

Ortho Clinical Diagnostics

Therakos

Veridex, LLC

The Vision Care Institute, LLC

Vistakon

 

Our long-term environmental goals serve as a roadmap for Johnson & Johnson to becoming one of the most environmentally responsible companies in the world. We report our progress each year in a Sustainability Report that covers environmental goals, business and social performance and charitable programs.

Johnson & Johnson Memberships in Associations

 

We are affiliated with many organizations through memberships, partnerships or sponsorships. A representative list of some of our social, environment and economic affiliations follows:

  • Academy for Educational Development
  • African Medical Research Foundation
  • American Academy of Pediatrics
  • AmeriCares
  • CEO Roundtable
  • Congressional Black Caucus Foundation
  • The Conservation Fund
  • International Rescue Committee
  • Mothers2Mothers
  • NAACP
  • National Council of La Raza
  • Partnership for Prescription Assistance
  • Partnership for Quality Medical Donations
  • PhRMA
  • Project JOPE
  • Safe Kids Worldwide
  • Together Rx
  • The Trust for Public Land
  • UCLA Anderson School of Management
  • UNICEF
  • U.S. Climate Action Partnership
  • World Resources Institute
  • World Wildlife Fund